Hydrogen peroxide-decomposing composite material and method for producing the same

By bonding polyvinylimidazole and metal porphyrins to a solid support, the composite material maintains catalytic activity for hydrogen peroxide decomposition in aqueous environments, addressing the loss of activity in previous materials and enabling effective hydrogen peroxide removal.

JP2024160835APending Publication Date: 2024-11-15TOKYO METROPOLITAN PUBLIC UNIVERSITY CORPORATION
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023076250
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-02
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Existing composite materials formed from polyvinylimidazole and metal porphyrins lose catalase activity when exposed to aqueous solutions, making them ineffective for hydrogen peroxide decomposition.

Method used

A composite material is developed by binding polyvinylimidazole and metal porphyrins to a solid support through non-covalent bonds, maintaining catalytic activity even in aqueous environments.

Benefits of technology

The composite material effectively decomposes hydrogen peroxide into oxygen and water while retaining activity in aqueous solutions, suitable for applications like hemodialysis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024160835000001_ABST
    Figure 2024160835000001_ABST
Patent Text Reader

Abstract

To provide a hydrogen peroxide-decomposing composite material that exhibits sustained catalytic activity for decomposing hydrogen peroxide, along with suppressed decomposition in aqueous solutions and a method for producing the same.SOLUTION: A hydrogen peroxide-decomposing composite material includes a solid support and a composite bound to the solid support, wherein the composite is capable of catalyzing the reaction that decomposes hydrogen peroxide into oxygen and water, and wherein the composite is formed from a polyvinyl imidazole, where the nitrogen at the 3-position of the imidazole ring is unsubstituted, or in some imidazole rings, the nitrogen at the 3-position is bound to an alkyl group or an alkenyl group, which is complexed with a metal porphyrin compound, where the central metal of the porphyrin structure is a manganese atom, an iron atom, a copper atom, or a selenium atom.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a composite material for decomposing hydrogen peroxide and a method for producing the same. Regarding. [Background technology]

[0002] Reactive oxygen species are believed to be involved in aging and many lifestyle-related diseases, and diseases that have been suggested to be related to reactive oxygen species generated in the body include arteriosclerosis, myocardial infarction, cancer, as well as Parkinson's disease, Alzheimer's disease, multiple sclerosis, cataracts, bronchial asthma, ulcerative colitis, diabetes, and autoimmune diseases.

[0003] Hydrogen peroxide (H2O2) is a representative molecule of reactive oxygen species (ROS), and while it is involved in signal transduction in the body and plays a role in protecting the body from antigens, it has been suggested that excessive amounts of H2O2 in the body may cause various serious diseases. Therefore, eliminating excess H2O2 using antioxidant enzymes with H2O2 scavenging activity (catalase activity) may have a significant effect on such diseases.

[0004] The inventors have been working on the molecular design of biomaterials that mimic catalase, which decomposes hydrogen peroxide into oxygen and water.

[0005] Non-Patent Document 1 discloses that complexes are formed between carboxymethyl poly(1-vinylimidazole) (CM-PVIm) and cationic Mn porphyrin, MnM4Py4P or MnP2Py4P, and that these complexes generate O2 from H2O2.

[0006] Non-Patent Document 2 discloses that a poly(1-vinylimidazole) (PVIm) derivative, which is mainly used as a gene carrier in the laboratory of the present inventors, was mixed with anionic iron porphyrin (Fe-TCPP) in a PBS solution, and that no significant oxygen generation from hydrogen peroxide was confirmed in the case of PVIm / Fe-TCPP, whereas oxygen generation was confirmed in the case of 1-methylimidazole (Me-Im) and anionic iron porphyrin (Fe-TCPP). [Prior art documents] [Non-patent literature]

[0007] [Non-Patent Document 1] The 62nd Annual Meeting of the Society of Polymer Science, Japan, Abstracts No. 62 ROMBUN NO.1 N23 Published on May 14, 2013 [Non-Patent Document 2] The 10th Annual Meeting of the Porphyrin-ALA Society, Abstracts p.34 March 2022 Summary of the Invention [Problem to be solved by the invention]

[0008] In the past, it was confirmed that when a polymer of an imidazole compound was mixed with a cationic Mn (manganese) porphyrin or an anionic Fe (iron) porphyrin in an aqueous solution, the complex formed exhibited catalase activity. However, because the solution was aqueous, the porphyrin decomposed and lost its catalase activity, making it difficult to put into practical use.

[0009] An object of the present invention is to provide a composite material for the decomposition of hydrogen peroxide that maintains catalytic activity for the decomposition of hydrogen peroxide while suppressing decomposition even in an aqueous solution, and a method for producing the same. [Means for solving the problem]

[0010] The present inventors have found that such a composite material for the decomposition of hydrogen peroxide can be produced by binding polyvinylimidazole to a metal porphyrin compound and then binding the resulting complex to a solid support, thereby completing the present invention.

[0011] The present invention encompasses the embodiments described below. Section 1. A solid support; a complex bound to a solid support, capable of catalyzing a reaction for decomposing hydrogen peroxide into oxygen and water, the complex comprising: a polyvinylimidazole in which the nitrogen at the 3-position of the imidazole ring is unsubstituted or in which an alkyl or alkenyl group is bound to the nitrogen at the 3-position of some of the imidazole rings; and a metalloporphyrin compound in which the central metal of the porphyrin skeleton is a manganese atom, an iron atom, a copper atom, or a selenium atom; A composite material for decomposing hydrogen peroxide comprising: Section 2. Item 2. The composite material for decomposing hydrogen peroxide according to Item 1, wherein the complex is bound to the solid support by a non-covalent bond, and the polyvinylimidazole and the metalloporphyrin compound are bound to each other by a non-covalent bond. Section 3. Item 3. The composite material for the decomposition of hydrogen peroxide according to item 1 or 2, wherein the composite is represented by the following formula (4):

[0012] [ka]

[0013] (In the formula, m is 0≦m<1, R is an optionally substituted alkyl group having 1 to 20 carbon atoms or an optionally substituted alkenyl group having 1 to 20 carbon atoms, and when the alkyl group having 1 to 20 carbon atoms or the alkenyl group having 1 to 20 carbon atoms is substituted, the substituent is at least one selected from the group consisting of a carboxy group, a hydroxy group, an amino group, and an amido group; Ar1, Ar2, Ar3, and Ar4 each independently represent a substituted or unsubstituted arylene group or a substituted or unsubstituted heteroaromatic ring group; M is a manganese atom, an iron atom, a copper atom, or a selenium atom; X - is COO - or SO3 - It is.) Section 4. Item 2. The composite material for decomposing hydrogen peroxide according to item 1, wherein the solid support is negatively charged and the polyvinylimidazole is non-covalently bound to the solid support. Section 5. Item 2. The composite material for decomposing hydrogen peroxide according to Item 1, wherein the solid support is a membrane that allows hydrogen peroxide to pass through. Section 6. Item 2. The composite material for the decomposition of hydrogen peroxide according to item 1, wherein an introduction rate of alkyl groups in the polyvinylimidazole is 1 mol % to 99 mol %. Section 7. Item 2. A composite material for the decomposition of hydrogen peroxide according to item 1, wherein the polyvinylimidazole has a number average molecular weight of 1,000 to 100,000. Section 8. Item 1. A composite material for decomposing hydrogen peroxide according to item 1, which is used for decomposing hydrogen peroxide in a biological sample. Section 9. A method for producing a composite material for decomposing hydrogen peroxide, comprising the steps of: Step (1): binding one of the following (i) and (ii) to a solid support: (i) Polyvinylimidazole in which the nitrogen at the 3-position of the imidazole ring is unsubstituted or an alkyl or alkenyl group is bonded to the nitrogen at the 3-position of some of the imidazole rings. (ii) A metalloporphyrin compound in which the central metal of the porphyrin skeleton is a manganese atom, an iron atom, a copper atom, or a selenium atom. , and Step (2): binding one of (i) and (ii) to the other of (i) and (ii) bound to the solid support; The method, wherein the (i) polyvinylimidazole and the (ii) metalloporphyrin compound bonded to each other are capable of catalyzing the reaction of decomposing hydrogen peroxide into oxygen and water. Section 10. Item 9. The method according to item 8, wherein the step (1) comprises contacting a negatively charged solid support with the polyvinylimidazole, and the step (2) comprises contacting the solid support contacted with the polyvinylimidazole with a metalloporphyrin compound. Section 11. Item 9. The method according to item 8, wherein the polyvinylimidazole is a compound represented by the following formula (1):

[0014] [ka]

[0015] (In the formula, m is 0≦m<1, R is an optionally substituted alkyl group having 1 to 20 carbon atoms or an optionally substituted alkenyl group having 1 to 20 carbon atoms, and when the alkyl group having 1 to 20 carbon atoms or the alkenyl group having 1 to 20 carbon atoms is substituted, the substituent is at least one selected from the group consisting of a carboxy group, a hydroxy group, an amino group, and an amido group. Section 12. Item 9. The method according to Item 8, wherein the metalloporphyrin compound is bound to the solid support in step (1) or bound to the polyvinylimidazole bound to a solid support in step (2), and the metalloporphyrin compound before binding in step (1) or step (2) is a compound represented by the following formula (3):

[0016] [ka]

[0017] (In the formula, Ar1, Ar2, Ar3, and Ar4 each independently represent a substituted or unsubstituted arylene group or a substituted or unsubstituted heteroaromatic ring group; M is a manganese atom, an iron atom, a copper atom, or a selenium atom; Y is COOH, SO3H, or a salt thereof. Effect of the Invention

[0018] According to the present invention, it is possible to provide a composite material for the decomposition of hydrogen peroxide, which maintains catalytic activity for the decomposition of hydrogen peroxide while suppressing decomposition even in an aqueous solution, and a method for producing the same. [Brief description of the drawings]

[0019] [Figure 1] Schematic diagram of hemodialysis using a composite material for decomposing hydrogen peroxide. [Diagram 2] 1H NMR spectrum of PVIm. [Diagram 3] Graph of GFC measurements for PVIm. [Figure 4] H NMR spectrum of PVIm-Me(25). [Diagram 5] 1H NMR spectrum of PVIm-Me(64). [Figure 6] 1H NMR spectrum of PVIm-Me(81). [Figure 7] 1H NMR spectrum of CM(35)-PVIm. [Figure 8] H NMR spectrum of PVIm-Oc(23). [Figure 9] 1H NMR spectrum of APPyP. [Figure 10] UV-Vis spectrum of Mn-APPyP solution. [Figure 11] UV-Vis spectra of membranes in contact with various PVIm-Me. [Figure 12](A)-(D) UV-Vis spectra of films in contact with each of PVIm-Me and Mn-TCCP. (A) PVIm-Me(20) / Mn-TCCP, (B) PVIm-Me(25) / Mn-TCCP, (C) PVIm-Me(64) / Mn-TCCP, (D) PVIm-Me(81) / Mn-TCCP [Figure 13] UV-Vis spectrum of the membrane (PVIm-Oc(23)) in contact with PVIm-Oc. [Figure 14] UV-Vis spectra of the membrane in contact with PVIm-Oc and Mn-TCPP (PVIm-Oc(23) / Mn-TCCP). [Figure 15] Adsorption amounts of PVIm derivatives and Mn-TCPP. [Figure 16] Adsorption amounts of PVIm derivatives and Fe-TCPP. [Figure 17] Oxygen production from various dialysis membranes. [Figure 18] (A)-(F) UV-Vis spectra of various membranes before and after dialysis. [Figure 19] (A)-(C) Photographs of the microdialysis device. [Figure 20] Hydrogen peroxide concentrations after dialysis using various membranes. [Figure 21] Oxygen production from hydrogen peroxide by various membranes in the presence of FBS. PVIm-Me(25) / Mn-TCPP in 10% FBS: PVIm-Me(25) / Mn-TCPP membrane incubated in the presence of 10% FBS with hydrogen peroxide, PVIm-Me(25) / Mn-TCPP in water: PVIm-Me(25) / Mn-TCPP membrane incubated in the absence of 10% FBS with hydrogen peroxide, Non-adsorbed in 10% FBS: Control membrane incubated in the presence of 10% FBS with hydrogen peroxide. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0020] In this specification, the term "comprise" is a concept that encompasses "consist essentially of" and "consist only of."

[0021] As used herein, "non-covalent bonds" refers to intermolecular interactions including electrostatic interactions (also called ionic bonds), hydrogen bonds, van der Waals forces, hydrophobic interactions, and coordinate bonds.

[0022] In the numerical ranges described in stages in this specification, the upper or lower limit of a certain numerical range can be arbitrarily combined with the upper or lower limit of another numerical range. In addition, in the numerical ranges described in this specification, the upper or lower limit of the numerical range may be replaced with a value shown in an example or a value that can be unambiguously derived from an example. Furthermore, in this specification, a numerical value connected with "~" means a numerical range that includes the numerical values ​​before and after "~" as the lower and upper limits.

[0023] In this specification, of the two nitrogens in each imidazole ring of polyvinylimidazole, the nitrogen bonded to a carbon of the polyvinyl chain is referred to as the 1-position nitrogen, and the nitrogen not bonded to a carbon of the polyvinyl chain is referred to as the 3-position nitrogen.

[0024] As used herein, a metalloporphyrin compound refers to a compound in which a metal is bound to the center of a porphyrin skeleton.

[0025] According to one aspect of the present invention, there is provided a composite material for the decomposition of hydrogen peroxide, comprising: a solid support; and a complex bound to the solid support, capable of catalyzing a reaction for decomposing hydrogen peroxide into oxygen and water, the complex comprising: polyvinylimidazole in which the nitrogen at position 3 of the imidazole ring is unsubstituted or in which an alkyl or alkenyl group is bound to the nitrogen at position 3 of some of the imidazole rings; and a metal porphyrin compound in which the central metal of the porphyrin skeleton is a manganese atom, an iron atom, a copper atom, or a selenium atom.

[0026] The solid support includes, but is not limited to, membranes, charged paper, beads, and any other type of solid support. The solid support is preferably made of a material that is negatively or positively charged at least on the surface to allow non-covalent binding with the complex. The solid support may be a single type of charged material, or may be a first material that is charged or uncharged and coated with a second material that is different in charge from the first material. The solid support may be made of, for example, nitrocellulose, cellulose acetate, polyester, polysulfone, or nylon. Nitrocellulose, cellulose acetate, polyester, and polysulfone are negatively charged, and nylon is positively charged. Membranes made of these materials are commercially available.

[0027] In one embodiment, the solid support is a membrane that allows hydrogen peroxide to pass through, which is advantageous in that the solid support allows hydrogen peroxide to pass through the membrane and be removed, thereby allowing both diffusion and filtration of hydrogen peroxide.

[0028] Polyvinylimidazole by itself usually does not have the effect of decomposing hydrogen peroxide into oxygen and water. A complex formed by combining a metal porphyrin compound with a polyvinylimidazole in which the nitrogen at the 3-position of the imidazole ring is unsubstituted or an alkyl or alkenyl group is bonded to the nitrogen at the 3-position of some of the imidazole rings, can catalyze the reaction of decomposing hydrogen peroxide into oxygen and water, but when left in water or an aqueous solution such as an aqueous solution, the metal porphyrin compound decomposes over time and cannot maintain its catalytic activity.

[0029] In the composite material for the decomposition of hydrogen peroxide according to an embodiment of the present invention, a complex formed by bonding polyvinylimidazole and a metal porphyrin compound is bonded to a solid support, and therefore, the decomposition of the complex can be suppressed while maintaining its catalytic activity.

[0030] The complex and the solid support may be bound by a non-covalent bond or a covalent bond. Preferably, the complex and the solid support are bound by a non-covalent bond. The polyvinylimidazole and the metalloporphyrin compound in the complex may be bound by a non-covalent bond or a covalent bond. Preferably, the polyvinylimidazole and the metalloporphyrin compound in the complex are bound by a non-covalent bond.

[0031] In a preferred embodiment, in the composite material for decomposing hydrogen peroxide, the complex is bound to the solid support by a non-covalent bond, and the polyvinylimidazole and the metalloporphyrin compound are bound to each other by a non-covalent bond.

[0032] For example, when the solid support is a negatively charged solid support, the polyvinylimidazole in the complex is bound to the solid support by a non-covalent bond including ionic and / or hydrogen bonds, or when the solid support is a positively charged solid support, the metalloporphyrin compound in the complex is bound to the solid support by a non-covalent bond including ionic and / or hydrogen bonds.

[0033] In one embodiment, when a substituent is bonded to the nitrogen at the 3rd position of the imidazole ring of the polyvinylimidazole, the substituent bonded to the nitrogen at the 3rd position of the imidazole ring of the polyvinylimidazole is an optionally substituted alkyl group having 1 to 20 carbon atoms or an optionally substituted alkenyl group having 1 to 20 carbon atoms, and when the alkyl group having 1 to 20 carbon atoms or the alkenyl group having 1 to 20 carbon atoms is substituted, the substituent is at least one selected from the group consisting of a carboxy group, a hydroxy group, an amino group, and an amide group. In one molecule of polyvinylimidazole, the substituent bonded to the nitrogen at the 3rd position of the imidazole ring may be one type or two or more types.

[0034] In one embodiment, the substituent is an unsubstituted alkyl group having 1 to 20 carbon atoms. In a further embodiment, the substituent is an unsubstituted alkyl group having 1 to 12 carbon atoms. In a further embodiment, the substituent is an unsubstituted alkyl group having 1 to 6 carbon atoms.

[0035] In another embodiment, the substituent is an unsubstituted alkenyl group having 1 to 20 carbon atoms. In a further embodiment, the substituent is an unsubstituted alkenyl group having 1 to 12 carbon atoms. In a further embodiment, the substituent is an unsubstituted alkenyl group having 1 to 6 carbon atoms.

[0036] When an alkyl group having 1 to 20 carbon atoms or an alkenyl group having 1 to 20 carbon atoms is substituted, the number of substituents in one alkyl group or alkenyl group is not particularly limited, but is preferably 1 to 3.

[0037] In one embodiment, the substituent is an alkyl group having 1 to 20 carbon atoms substituted with a carboxy group, a hydroxy group, an amino group, or an amido group. In a further embodiment, the substituent is a carboxyalkyl group, a hydroxyalkyl group, an aminoalkyl group, or an amidoalkyl group having 1 to 20 carbon atoms.

[0038] In one embodiment, the substituent is an alkenyl group having 1 to 20 carbon atoms substituted with a carboxy group, a hydroxy group, an amino group, or an amido group. In a further embodiment, the substituent is a carboxyalkenyl group, a hydroxyalkenyl group, an aminoalkenyl group, or an amidoalkenyl group having 1 to 20 carbon atoms.

[0039] In one embodiment, the polyvinylimidazole that forms the complex is a compound represented by the following formula (1).

[0040] [ka]

[0041] (In the formula, m satisfies 0 ≦ m < 1, R is an optionally substituted alkyl group having 1 to 20 carbon atoms or an optionally substituted alkenyl group having 1 to 20 carbon atoms. When the alkyl group having 1 to 20 carbon atoms or the alkenyl group having 1 to 20 carbon atoms is substituted, the substituent is at least one selected from the group consisting of a carboxy group, a hydroxy group, an amino group, and an amide group.)

[0042] When m is 0, the nitrogen at the 3-position of the imidazole ring is unsubstituted. When 0 < m < 1, an alkyl group or an alkenyl group is bonded to the nitrogen at the 3-position of some of the imidazole rings.)

[0043] Since the larger the number of carbon atoms in the alkyl group or alkenyl group of R, the higher the hydrophobicity and the greater the binding or adsorption to the solid support, but when the number of carbon atoms in the alkyl group or alkenyl group of R is large, the space occupied by R becomes large, and it becomes difficult to bind to the metal porphyrin compound due to steric hindrance of the functional group. Therefore, the number of carbon atoms in the alkyl group or alkenyl group of R is preferably 1 to 20.)

[0044] In one embodiment, R is an unsubstituted alkyl group having 1 to 20 carbon atoms. In a further embodiment, R is an unsubstituted alkyl group having 1 to 12 carbon atoms. In a further embodiment, R is an unsubstituted alkyl group having 1 to 6 carbon atoms.)

[0045] In another embodiment, R is an unsubstituted alkenyl group having 1 to 20 carbon atoms. In a further embodiment, R is an unsubstituted alkenyl group having 1 to 12 carbon atoms. In a further embodiment, R is an unsubstituted alkenyl group having 1 to 6 carbon atoms.)

[0046] When the alkyl group having 1 to 20 carbon atoms or the alkenyl group having 1 to 20 carbon atoms is substituted, the number of substituents in one alkyl group or alkenyl group is not particularly limited, but is preferably 1 to 3.)

[0047] In one embodiment, R is an alkyl group having 1 to 20 carbon atoms substituted with a carboxy group, a hydroxy group, an amino group, or an amido group. In a further embodiment, R is a carboxyalkyl group, a hydroxyalkyl group, an aminoalkyl group, or an amidoalkyl group having 1 to 20 carbon atoms.

[0048] In one embodiment, R is an alkenyl group having 1 to 20 carbon atoms substituted with a carboxy group, a hydroxy group, an amino group, or an amido group. In a further embodiment, R is a carboxyalkenyl group, a hydroxyalkenyl group, an aminoalkenyl group, or an amidoalkenyl group having 1 to 20 carbon atoms.

[0049] The compound represented by formula (1) is advantageous in that the more the R group is modified, the more the number of binding sites with the metal porphyrin compound increases, but on the other hand, the more the charge increases, the more hydrophilic the compound becomes, and the more easily it is removed from the solid support. For this reason, it is considered that it is better to have a certain degree of hydrophobicity. In terms of binding to the solid support, m is preferably 0.05≦m≦0.95, and preferably 0.10≦m≦0.90. In terms of the hydrophobicity of the compound represented by formula (1), m is more preferably 0.50 or less (m≦0.50). In terms of binding to the solid support, in a particular preferred embodiment, m is 0.10≦m≦0.40.

[0050] The molecular weight of the polyvinylimidazole that forms the above complex is not particularly limited, but from the viewpoint of uniformity and stability of binding of the complex to the solid support, a number average molecular weight of 1,000 to 100,000 is preferable.

[0051] Metalloporphyrin compounds can also be written as X-porphyrin compounds (X is a metal), and refer to complex compounds in which X (metal) is bonded to the four nitrogen atoms of a compound having a porphyrin ring. For example, Mn-porphyrin compounds refer to complex compounds in which manganese is bound to the four nitrogen atoms of a compound having a porphyrin ring, and Fe-porphyrin compounds refer to complex compounds in which iron is bound to the four nitrogen atoms of a compound having a porphyrin ring.

[0052] In one embodiment, the metalloporphyrin compound that forms the complex is a compound represented by the following formula (2).

[0053] [ka]

[0054] (In the formula, Ar1, Ar2, Ar3, and Ar4 each independently represent a substituted or unsubstituted arylene group or a substituted or unsubstituted heteroaromatic ring group; M is a manganese atom, an iron atom, a copper atom, or a selenium atom; X - is COO - or SO3 - It is.)

[0055] Ar1, Ar2, Ar3, and Ar4 may be the same or may be two or more different groups. In one preferred embodiment, Ar1, Ar2, Ar3, and Ar4 are the same.

[0056] When Ar1, Ar2, Ar3, and Ar4 are substituted or unsubstituted arylene groups, the number of carbon atoms in the aryl group is preferably 6 to 14. When Ar1, Ar2, Ar3, and Ar4 are substituted arylene groups, the substituent is at least one substituent selected from the group consisting of an alkyl group having 1 to 4 carbon atoms and a halogen. The alkyl group having 1 to 4 carbon atoms may be any of linear, branched, and cyclic alkyl groups, and examples thereof include a methyl group, an ethyl group, a propyl group, a 2-methylpropyl group, an isopropyl group, a cyclopropyl group, a butyl group, a 2-butyl group, a tert-butyl group, and a cyclobutyl group. Examples of halogen atoms include fluorine, chlorine, bromine, and iodine.

[0057] Examples of the aryl group having 6 to 14 carbon atoms include a phenyl group, a 1-naphthyl group, a 2-naphthyl group, a 2-biphenylyl group, a 3-biphenylyl group, a 4-biphenylyl group, a 3,5-terphenylyl group, a 1-anthryl group, a 2-anthryl group, a 9-anthryl group, a 1-phenanthrenyl group, a 2-phenanthrenyl group, a 3-phenanthrenyl group, a 4-phenanthrenyl group, a 9-phenanthrenyl group, a 1-fluorenyl group, Examples of the fluorenyl group include 2-fluorenyl group, 3-fluorenyl group, 4-fluorenyl group, 9,9-dimethyl-9H-fluoren-1-yl group, 9,9-dimethyl-9H-fluoren-2-yl group, 9,9-dimethyl-9H-fluoren-3-yl group, 9,9-dimethyl-9H-fluoren-4-yl group, 1-pyrenyl group, 2-pyrenyl group, 9-pyrenyl group, 1-triphenylenyl group, and 2-triphenylenyl group. A phenyl group is preferred in terms of ease of synthesis of the compound represented by formula (2).

[0058] When Ar1, Ar2, Ar3, and Ar4 are substituted or unsubstituted heteroaromatic groups, the number of carbon atoms in the heteroaromatic group is preferably 3 to 18. When Ar1, Ar2, Ar3, and Ar4 are substituted heteroaromatic groups, the substituent is at least one substituent selected from the group consisting of an alkyl group having 1 to 4 carbon atoms and a halogen. The alkyl group having 1 to 4 carbon atoms may be any of linear, branched, and cyclic alkyl groups, and examples thereof include a methyl group, an ethyl group, a propyl group, a 2-methylpropyl group, an isopropyl group, a cyclopropyl group, a butyl group, a 2-butyl group, a tert-butyl group, and a cyclobutyl group. Examples of halogen atoms include fluorine, chlorine, bromine, and iodine.

[0059] Examples of heteroaromatic groups having 3 to 18 carbon atoms include a 2-furanyl group, a 3-furanyl group, a 2-thienyl group, a 3-thienyl group, a 1-pyrrolyl group, a 2-pyrrolyl group, a 3-pyrrolyl group, a 2-pyridyl group, a 3-pyridyl group, a 4-pyridyl group, a 2-quinolyl group, a 3-quinolyl group, a 4-quinolyl group, a 5-quinolyl group, a 6-quinolyl group, a 7-quinolyl group, an 8-quinolyl group, a 2-benzofuranyl group, a 3-benzofuranyl group, a 2-benzothienyl group, a 3-benzothienyl group, a 1-indolyl group, a 2-indolyl group, a 3-indolyl group, Examples of such groups include a 1-carbazoyl group, a 2-carbazoyl group, a 3-carbazoyl group, a 4-carbazoyl group, a 9-phenyl-9H-carbazol-1-yl group, a 9-phenyl-9H-carbazol-2-yl group, a 9-phenyl-9H-carbazol-3-yl group, a 9-phenyl-9H-carbazol-4-yl group, a dibenzofuran-2-yl group, a dibenzofuran-3-yl group, a dibenzofuran-4-yl group, a dibenzothiophen-2-yl group, a dibenzothiophen-3-yl group, and a dibenzothiophen-4-yl group. In view of ease of synthesis of the compound represented by formula (2), a 2-pyridyl group, a 3-pyridyl group, or a 4-pyridyl group is preferred, and a 4-pyridyl group is particularly preferred in view of the absence of rotamers.

[0060] In terms of the amount adsorbed to the solid support, M is preferably a manganese atom or an iron atom, and more preferably a manganese atom.

[0061] In one embodiment, the complex may be a complex represented by the following formula (4):

[0062] [ka]

[0063] (In the formula, m is 0≦m<1, R is an optionally substituted alkyl group having 1 to 20 carbon atoms or an optionally substituted alkenyl group having 1 to 20 carbon atoms, and when the alkyl group having 1 to 20 carbon atoms or the alkenyl group having 1 to 20 carbon atoms is substituted, the substituent is at least one selected from the group consisting of a carboxy group, a hydroxy group, an amino group, and an amido group; Ar1, Ar2, Ar3, and Ar4 each independently represent a substituted or unsubstituted arylene group or a substituted or unsubstituted heteroaromatic ring group; M is a manganese atom, an iron atom, a copper atom, or a selenium atom; X - is COO - or SO3 - It is.)

[0064] Details of m, R, Ar1, Ar2, Ar3, and Ar4 are as described for the compounds of formula (1) and formula (2).

[0065] In one embodiment, the introduction rate of the alkyl group in the polyvinylimidazole is 0 mol% to 99 mol%. In a further embodiment, the composite is a composite represented by the following formula (4), in which R in formula (4) is an alkyl group, and the introduction rate of the alkyl group in the polyvinylimidazole is 0 mol% to 99 mol% (m is 0.01 to 0.99).

[0066] In one embodiment, an alkyl group is bonded to the nitrogen at the 3-position of a part of the imidazole rings of the polyvinylimidazole, and the introduction rate of the alkyl group in the polyvinylimidazole is 1 mol% to 99 mol%. In a further embodiment, the complex is a complex represented by the following formula (4), R in formula (4) is an alkyl group, and the introduction rate of the alkyl group in the polyvinylimidazole is 1 mol% to 99 mol% (m is 0.01 to 0.99).

[0067] The composite material for the decomposition of hydrogen peroxide according to the embodiment of the present invention can be widely used for decomposing hydrogen peroxide. For example, the composite material for the decomposition of hydrogen peroxide according to the embodiment of the present invention can be used for decomposing hydrogen peroxide in a biological sample. Examples of the biological sample include, but are not limited to, blood (whole blood, serum, plasma), urine, lymph, and the like. By contacting the biological sample with the composite material for the decomposition of hydrogen peroxide according to the embodiment of the present invention, hydrogen peroxide can be decomposed into oxygen and hydrogen.

[0068] The composite material for decomposing hydrogen peroxide according to the embodiment of the present invention may be used in vitro or in vivo. When used in vitro, the composite material for decomposing hydrogen peroxide according to the embodiment of the present invention may be used as a dialysis membrane, a biological sample taken from a living body such as a human being may be brought into contact with the composite material for decomposing hydrogen peroxide, and the biological sample after contact may be returned to the living body. For example, the composite material for decomposing hydrogen peroxide according to the embodiment of the present invention may be used in hemodialysis of a patient with kidney disease (FIG. 1). The composite material for decomposing hydrogen peroxide 10 according to the embodiment of the present invention acts as a dialysis membrane, and by bringing blood into contact with the composite material for decomposing hydrogen peroxide during hemodialysis, harmful hydrogen peroxide can be disproportionated and detoxified into water and oxygen.

[0069] In one embodiment, the composite material for decomposing hydrogen peroxide is a composite material in which, when 1 mM H2O2 is passed through the composite material, the concentration of H2O2 is reduced to about 750 μM or less compared to before the passage.

[0070] In another embodiment, the composite material for decomposing hydrogen peroxide is a composite material in which, when 1 mM H2O2 is passed through the composite material, the concentration of H2O2 is reduced by about 75% or less compared to a control material not containing the composite material.

[0071] In another embodiment, the composite material for decomposing hydrogen peroxide is a composite material in which, when 1 mM H2O2 is passed through the composite material, the amount of O2 generated becomes about 18 μM or more after the passage starts. The amount of O2 generated may be about 18 μM or more at any time after the passage starts through the composite material.

[0072] In another embodiment, the composite material for decomposing hydrogen peroxide has a structure in which, when 1 mM H2 O2 is passed through the composite material, the amount of O2 generated is 10 times greater than that of a control material not containing the composite material after the start of the passage of 1 mM H2 O2. 6 times or more, preferably 10 12 It is a composite material that is more than twice as thick.

[0073] In another embodiment, the composite material for decomposing hydrogen peroxide has a change rate of 10% or less, preferably 5% or less, more preferably 1% or less, and even more preferably 10% or less, in absorbance at a wavelength corresponding to metalloporphyrin in the UV-visible spectrum after one use in which 1 mM H2O2 is passed through the composite material, compared to the absorbance at a wavelength corresponding to metalloporphyrin in the UV-visible spectrum before use. -12 % or less. The rate of change is calculated as {(absorbance of the wavelength corresponding to the metal porphyrin in the UV-visible spectrum when unused) - (absorbance of the wavelength corresponding to the metal porphyrin in the UV-visible spectrum after one use)} / (absorbance of the wavelength corresponding to the metal porphyrin in the UV-visible spectrum when unused) * 100.

[0074] According to one aspect of the present invention, there is provided a method for producing a composite material for decomposing hydrogen peroxide, comprising the steps of: Step (1): binding one of the following (i) and (ii) to a solid support: (i) Polyvinylimidazole in which the nitrogen at the 3-position of the imidazole ring is unsubstituted or an alkyl or alkenyl group is bonded to the nitrogen at the 3-position of some of the imidazole rings. (ii) A metalloporphyrin compound in which the central metal of the porphyrin skeleton is a manganese atom, an iron atom, a copper atom, or a selenium atom. , and Step (2): binding one of (i) and (ii) to the other of (i) and (ii) bound to the solid support; A method is provided, wherein the (i) polyvinylimidazole and the (ii) metalloporphyrin compound bonded to each other are capable of catalyzing the reaction of decomposing hydrogen peroxide into oxygen and water.

[0075] The nitrogen at position 3 of the imidazole ring of polyvinylimidazole may be unsubstituted or substituted with an alkyl or alkenyl group.

[0076] Polyvinylimidazole having an alkyl or alkenyl group bonded to the nitrogen 3-position of some of the imidazole rings can be produced by dissolving polyvinylimidazole and an alkyl or alkenyl halide in an appropriate ratio in 3 ml of dehydrated DMF, reacting them, purifying the reaction product by a known purification method (e.g., dialysis, precipitation purification, gel filtration, etc.) as necessary, and drying by a known drying method (e.g., natural drying, lyophilization, vacuum drying, etc.) as necessary. Alternatively, polyvinylimidazole having an alkyl or alkenyl group bonded to the nitrogen 3-position of some of the imidazole rings can also be produced according to the method described in Asahima et al. Bioconjugate Chem. 2010, 21, 646-652.

[0077] Metal porphyrin compounds can be produced by known production methods such as the method described in Harada et al. Inorg. Chem. 1997, 36, 6099-6102, or commercially available products can be used. For example, Mn-porphyrin compounds can be produced by adding manganese acetate (II) tetrahydrate to an aqueous solution containing a porphyrin compound, and Fe-porphyrin compounds can be produced by adding iron chloride (FeCl3) tetrahydrate to an aqueous solution containing a porphyrin compound, incubating at a constant temperature for a certain period of time to form a complex, purifying the reaction product by a known purification method (e.g., dialysis, precipitation purification, gel filtration, etc.) as necessary, and drying by a known drying method (e.g., natural drying, freeze drying, vacuum drying, etc.) as necessary. The incubation temperature is not particularly limited, but is, for example, 4 to 50° C. The incubation time is not particularly limited, but is, for example, 30 minutes to 24 hours.

[0078] In step (1), the solid support and one of (i) and (ii) may be bound by a non-covalent bond or a covalent bond. Preferably, the solid support and one of (i) and (ii) are bound by a non-covalent bond.

[0079] In step (2), one of (i) and (ii) bound to the solid support may be bound to the other of (i) and (ii) by a non-covalent bond or a covalent bond. Preferably, one of (i) and (ii) bound to the solid support is bound to the other of (i) and (ii) by a non-covalent bond.

[0080] In a preferred embodiment, in step (1), one of (i) and (ii) is bound to the solid support via a non-covalent bond, and in step (2), one of (i) and (ii) bound to the solid support is bound to the other of (i) and (ii) via a non-covalent bond.

[0081] In one embodiment, the step (1) includes contacting a negatively charged solid support with the polyvinylimidazole, and the step (2) includes contacting the solid support contacted with the polyvinylimidazole with a metalloporphyrin compound. In this manner, a first molecule is bound to a solid support by utilizing intermolecular electrostatic interaction, and a second molecule is sequentially bound to the first molecule, thereby non-covalently binding the complex to the solid support in a layer-by-layer manner. Steps (1) and (2) may be performed in an aqueous solution.

[0082] In another embodiment, the step (1) comprises contacting a positively charged solid support with the metalloporphyrin compound, and the step (2) comprises contacting the solid support contacted with the metalloporphyrin compound with polyvinylimidazole. In this case, too, the complex can be non-covalently bound to the solid support in a layer-by-layer manner. Steps (1) and (2) may be carried out in an aqueous solution.

[0083] In one embodiment, the polyvinylimidazole is a compound represented by the following formula (1):

[0084] [ka]

[0085] (In the formula, m is 0≦m<1, R is an optionally substituted alkyl group having 1 to 20 carbon atoms or an optionally substituted alkenyl group having 1 to 20 carbon atoms, and when the alkyl group having 1 to 20 carbon atoms or the alkenyl group having 1 to 20 carbon atoms is substituted, the substituent is at least one selected from the group consisting of a carboxy group, a hydroxy group, an amino group, and an amido group.

[0086] Details of the compound represented by formula (1) are as explained above.

[0087] In one embodiment, the metalloporphyrin compound is bound to the solid support in step (1) or bound to the polyvinylimidazole bound to a solid support in step (2), and the metalloporphyrin compound before binding in step (1) or step (2) is a compound represented by the following formula (3):

[0088] [ka]

[0089] (In the formula, Ar1, Ar2, Ar3, and Ar4 each independently represent a substituted or unsubstituted arylene group or a substituted or unsubstituted heteroaromatic ring group; M is a manganese atom, an iron atom, a copper atom, or a selenium atom; Y is -COOH, -SO3H, or a salt thereof.

[0090] Ar1, Ar2, Ar3, and Ar4 are as described in relation to formula (2).

[0091] When Y is a salt of COOH or SO3H, it may be a metal salt (e.g., an alkali metal salt such as a sodium salt or a potassium salt) or a non-metal salt (e.g., an ammonium salt or a guanidinium salt).

[0092] The disclosures of all patent applications and publications cited herein are hereby incorporated by reference in their entireties.

[0093] The following examples are intended for illustrative purposes only and are not intended to limit the scope of the present invention in any way. Unless otherwise specified, reagents are commercially available or are obtained or prepared according to conventional techniques or procedures known in the art. EXAMPLES

[0094] 1. Synthesis of polyvinylimidazole (PVIm) derivatives Preparation Example 1 Synthesis of polyvinylimidazole (PVIm) In a vial, 99.2 mg (0.61 mmol) of azobisisobutyronitrile (AIBN) and 2 ml of 1-vinylimidazole (VIm) (11 mmol) were dissolved in 10 ml of dehydrated N,N-dimethylformamide (DMF). Nitrogen bubbling was performed for about 3 hours, and then the mixture was incubated in a water bath at 65°C for about 24 hours. Reprecipitation was performed with acetone, the supernatant was removed, and the mixture was centrifuged (3°C, 1×10 5The precipitate was separated at 37° C. for 10 min at 37° C. (rpm), and the supernatant was removed and the precipitate was washed. The precipitate was dissolved in water and dialyzed for 2 days using a commercially available regenerated cellulose dialysis membrane with a MWCO of 1000. The precipitate was then freeze-dried for 3 days.

[0095] The resulting product was dissolved in 600 μL of deuterium oxide. 1 H NMR was measured. A 1.0 mg / mL PVIm solution was also prepared and subjected to GFC measurement (carrier: 0.5 M CH3COOH, 0.2 M NaNO3).

[0096] 1 The results of H NMR are shown in Figure 2. The progress of synthesis was confirmed by assignment of the integral value of protons. The results of GFC measurement are shown in Figure 3. The molecular weight of the polymerized PVIm was Mw = 6.6 × 10 3 (Mw / Mn = 4.1) In the production examples of the present invention, the molecular weight of the polymer from the GFC measurement results was calculated by creating a calibration curve using monodisperse PEG.

[0097] In the following Production Examples and Examples, unless otherwise specified, a regenerated cellulose membrane having a MWCO of 1000 was used.

[0098] Preparation Example 2 Synthesis of methylated polyvinylimidazole (PVIm-Me(25)) In a vial, 53.0 mg of PVIm (repeating unit: 94 g / mol, 1.1 mmol) and 7.6 μl of iodomethane (141.9 g / mol, 2.28 g / cm 3 , 23 mol%, 0.23 mmol) was dissolved in 3 ml of dehydrated DMF and stirred at room temperature for about 24 hours. Dialysis was performed for 3 days using a dialysis membrane with MWCO 1000. Next, freeze-drying was performed for 2 days.

[0099] The resulting product was dissolved in 600 μL of deuterium oxide. 1 H NMR was measured. 1 The results of HNMR are shown in Figure 4. The progress of synthesis was confirmed by assignment of the integral values ​​of protons. The modification rate was 25 mol%.

[0100] Preparation Example 3 Synthesis of methylated polyvinylimidazole (PVIm-Me(64)) In a vial, 106.6 mg of PVIm (repeating unit: 94 g / mol, 1.1 mmol) and 42.0 μl of iodomethane (141.9 g / mol, 2.28 g / cm 3 , 63 mol%, 0.63 mmol) was dissolved in 3 ml of dehydrated DMF and stirred at room temperature for about 24 hours. Dialysis was performed for 3 days using a dialysis membrane with MWCO 1000. Next, freeze-drying was performed for 2 days.

[0101] The resulting product was dissolved in 600 μL of deuterium oxide. 1 H NMR was measured. 1 The results of HNMR are shown in Figure 5. The progress of synthesis was confirmed by assignment of the integral value of protons. The modification rate was 64 mol%.

[0102] Preparation Example 4 Synthesis of methylated polyvinylimidazole (PVIm-Me(81)) In a vial, 49.7 mg of PVIm (repeating unit: 94 g / mol, 1.1 mmol) and 26.3 μl of iodomethane (141.9 g / mol, 2.28 g / cm 3 , 85 mol%, 0.85 mmol) was dissolved in 3 ml of dehydrated DMF and stirred at room temperature for about 24 hours. Dialysis was performed for 3 days using a dialysis membrane with MWCO 1000. Next, freeze-drying was performed for 2 days.

[0103] The resulting product was dissolved in 600 μL of deuterium oxide. 1 H NMR was measured. 1 The results of HNMR are shown in Figure 6. The progress of synthesis was confirmed by assignment of the integral value of protons. The modification rate was 81 mol%.

[0104] Preparation Example 5 Synthesis of carboxypolyvinylimidazole (CM(35)-PVIm) 38.2 mg of PVIm (repeating unit: 94 g / mol, 1.1 mmol) and 22.8 mg of iodoacetic acid (185.95 g / mol) (30% charge, 0.32 mmol) were weighed into a vial, 3 mL of dehydrated DMF was added, and the mixture was stirred vigorously at room temperature for 24 h. The mixture was dialyzed for 3 days using a MWCO 1000 dialysis membrane. The mixture was then freeze-dried for 2 days.

[0105] The resulting product was dissolved in deuterated DMSO by incubation with TFA. 1 H NMR was measured. 1 The results of H NMR are shown in Figure 7. The progress of synthesis was confirmed by assignment of the integral values ​​of protons. The modification rate was 35 mol%.

[0106] Preparation Example 6 Synthesis of octylated polyvinylimidazole (PVIm-Oc(23)) In a vial, 188 mg of PVIm (repeating unit: 94 g / mol, 1.1 mmol) and 104 μl of 1-bromooctane (193.13 g / mol, 1.11 g / cm 3 , 60 mol%, 0.60 mmol) was dissolved in 6 ml of dehydrated DMF and stirred at 40° C. for about 24 hours. Reprecipitation was carried out with acetone, and the precipitate was dissolved in a small amount of ion-exchanged water. Dialysis was performed for 3 days using a dialysis membrane with MWCO 500-1000, followed by freeze-drying for 2 days.

[0107] The resulting product was dissolved in 600 μL of deuterium oxide. 1 H NMR was measured. 1 The results of HNMR are shown in Figure 8. The progress of synthesis was confirmed by assignment of the integral value of protons. The modification rate was 23 mol%.

[0108] 2. Synthesis of porphyrin compounds Production Example 7 Synthesis of aminopropylpyridylporphyrin (APPyP) Pyridylporphyrin (PyP) 60 mg (0.097 mmol) and 3-bromopropylamine (3-BPA) 400 mg (1.827 mmol) were added to 12 ml of DMF. The mixture was stirred in an oil bath at 140°C for about 24 hours under a nitrogen atmosphere. The reaction solution was precipitated by adding acetone and the supernatant was removed several times. The precipitate was dissolved in distilled water, frozen in liquid nitrogen, and freeze-dried for one day.

[0109] The solvent used was dimethyl sulfoxide (DMSO-D6). 1 HNMR analysis was performed. As shown in FIG. 1 The synthesis of APPyP was confirmed by HNMR analysis.

[0110] [ka]

[0111] Production Example 8 Synthesis of iron tetrakis(4-carboxyphenyl)porphyrin (Fe-TCPP) Fe-TCPP was synthesized according to the method described by Harada et al. Inorg. Chem. 1997, 36, 6099-6102.

[0112] [ka]

[0113] Preparation Example 9 Synthesis of manganese-coordinated aminopropylpyridylporphyrin (Mn-APPyP) APPyP 28.99 mg (1.9 × 10 -2 mmol), manganese(II) acetate tetrahydrate 47.68 mg (1.9 × 10 -1 The mixture was incubated at 37°C for 3 hours to allow the reaction to proceed. Dialysis was performed using a dialysis membrane with MWCO 100-500 for 4 hours. Then, the mixture was freeze-dried.

[0114] The reaction product was measured using a UV-Vis spectrophotometer. As shown in Figure 10, the maximum absorption wavelength of APPyP shifted from 424 nm to 463 nm, confirming the incorporation of Mn.

[0115] [ka]

[0116] Production Example 10 Synthesis of manganese tetrakis(4-carboxyphenyl)porphyrin (Mn-TCPP) Mn-TCPP was synthesized according to the method described by Harada et al. Inorg. Chem. 1997, 36, 6099-6102.

[0117] [ka]

[0118] 3. Adsorption of the complex to the membrane Example 1 Adsorption of PVIm-Me and Mn-TCPP complex onto membrane A dialysis membrane with MWCO 1000 was left to stand for 24 hours in 3 ml of each PVIm-Me solution (solution concentration: 5.10 mg / ml, modification rate: 20, 25, 64, 81 mol%) produced in Production Examples 1 to 4. Next, the dialysis membrane was left to stand for 24 hours in 3 ml of Mn-TCPP solution (solution concentration: 1.15 mg / ml). The produced modified membrane was measured with a UV-Vis spectrophotometer.

[0119] (result) No characteristic peak was observed in the membrane after contact with PVIm-Me (Figure 11). The peaks of Mn-TCPP were confirmed in the membrane that came into contact with PVIm-Me and Mn-TCPP (Figures 12(A)-(D)). Note that the amount of adsorption to the membrane was also measured using Mn-APPyP, a cationic porphyrin, instead of the Mn-TCPP solution, but the absorbance of Mn-APPyP decreased significantly within 30 minutes, confirming that it was decomposed by hydrogen peroxide (data not shown).

[0120] Example 2 Adsorption of PVIm-Oc and Mn-TCPP complex onto membrane A dialysis membrane with MWCO 1000 was left to stand for 24 hours in 3 ml of PVIm-OC (solution concentration: 5.10 mg / ml, modification rate: 23 mol%) prepared in Preparation Example 6. Next, the dialysis membrane was left to stand for 24 hours in 3 ml of Mn-TCPP solution (solution concentration: 1.15 mg / ml). The prepared modified membrane was measured with a UV-Vis spectrophotometer.

[0121] (result) No characteristic peak was observed in the membrane after contact with PVIm-Oc (Figure 13). A peak of Mn-TCPP was confirmed in the membrane after contact with PVIm-Oc and Mn-TCPP (Figure 14).

[0122] From the results of Examples 1 and 2, the amounts of the PVIm derivatives and Mn-TCPP adsorbed to the dialysis membrane were measured based on the calibration curves of the PVIm derivatives and Mn-TCPP of known concentrations (FIG. 15).

[0123] Among the PVIm derivatives, PVIm-Oc(23) had the highest adsorption to the membrane. This is because the octyl group is a longer hydrophobic group than the methyl group, and it is thought that hydrophobic interactions as well as electrostatic interactions are involved in the binding to the dialysis membrane. As for PVIm-Me, the adsorption amount was higher as the degree of modification with methyl was lower. This may be due to the hydrophobic environment of the free imidazole group and cellulose in addition to electrostatic interactions.

[0124] Regarding the amount of Mn-TCPP adsorbed to the membrane, in the case of PVIm-Me, the amount of Mn-TCPP adsorbed to the membrane increases almost in proportion to the amount of the polymer adsorbed. Comparing PVIm-Me(25) and PVIm-Oc(23), the amount of adsorption of the PVIm derivative Oc(23) is higher, but the amount of Mn-TCPP adsorbed is higher for Me(25). This is thought to be due to steric hindrance occurring because the octyl group is a longer hydrophobic group than the methyl group.

[0125] Example 3 Evaluation of catalytic activity on the membrane surface by PVIm derivative / Fe-TCCP In Example 2, Fe-TCPP was used instead of Mn-TCPP to measure the amounts of PVIm derivatives and Mn-TCPP adsorbed onto the dialysis membrane.

[0126] (result) The adsorption amounts of PVIm derivatives and Mn-TCPP to the regenerated cellulose membrane are shown in Figure 16. The adsorption amount of Fe-TCPP was generally lower than that of Mn-TCPP shown in Figure 15. The reason for this is thought to be the difference in axial ligands. Mn-TCPP is more likely to have imidazole groups coordinate, while Fe-TCPP is more likely to have OH groups coordinate, which is thought to have resulted in the difference in adsorption amounts.

[0127] Similar to the adsorption amount of Mn-TCPP, the highest polymer adsorption amount was PVIm-Oc(23), which is thought to be due to the fact that the octyl group is a longer hydrophobic group than the methyl group, and therefore hydrophobic interactions as well as electrostatic interactions are involved in the binding with the dialysis membrane. As for PVIm-Me, the lower the introduction rate, the higher the adsorption amount. This may be due to the hydrophobic environment of the free imidazole groups and cellulose, in addition to electrostatic interactions.

[0128] Comparing the amount of adsorption of Fe-TCPP, Me(25) and Me(64), the amount of polymer adsorption was higher for Me(25), but the amount of Fe-TCPP adsorption was higher for Me(64). This is thought to be related to the fact that the difference in the amount of polymer adsorption was small and that Me(64) has a larger number of cations.

[0129] Comparing PVIm-Me(25) and PVIm-Oc(23), the amount of polymer adsorbed is much higher for Oc(23), but the difference in the amount of Fe-TCPP adsorbed is small. This is thought to be due to steric hindrance caused by the hydrophobic group of the octyl group being longer than that of the methyl group.

[0130] Example 4: Measurement of oxygen production using an oxygen electrode A control membrane (a regenerated cellulose membrane soaked in distilled water for 48 hours), a membrane contacted with PVIm-Me (25), a membrane contacted with Mn-TCPP, and the various PVIm derivatives and TCPP prepared in Examples 1 and 2 were contacted. The dialysis membrane was directly placed in a Clark-type oxygen electrode, and 900 μl of distilled water was added and the electrode was left to stand until the value stabilized. After the value stabilized, 100 μl of 10 mM hydrogen peroxide was added and measurements were performed (final concentration 1 mM). After the experiment, the dialysis membrane was measured using a UV-Vis spectrophotometer to evaluate the generation of oxygen, which is the product of the catalytic reaction.

[0131] (result) The control membrane, PVIm-Me(25) membrane, and Mn-TCPP membrane produced nearly zero oxygen, whereas oxygen generation was confirmed in the membrane with the polymer and Mn-TCPP adsorbed (Figure 17). Furthermore, while the amount of adsorption in the Mn-CPP membrane decreased before and after the experiment, the amount of Mn-TCPP adsorbed could be maintained by modifying it with the PVIm derivative polymer (Figure 18). The membrane with the highest oxygen production was the PVIm-Me(20) / Mn-TCPP membrane, and the membrane that was able to maintain the adsorption amount the most and produced the highest oxygen was the PVIm-Me(25) / Mn-TCPP membrane.

[0132] It is believed that the imidazole group of PVIm was easily coordinated to Mn-TCPP by modifying the polymer, resulting in strong adsorption. The PVIm-Me(81) / Mn-TCPP membrane had a low adsorption amount of PVIm-Me(81), and therefore a low adsorption amount of Mn-TCPP, and the decrease in the adsorption amount after the experiment was also larger than that of the other dialysis membranes.

[0133] Example 5 Evaluation of hydrogen peroxide decomposition The decomposition of hydrogen peroxide, which is the substrate for the catalytic reaction, was evaluated.

[0134] The microdialysis device shown in Fig. 19(A)-(C) was used. The microdialysis device includes a first member 1, a second member 2, and a third member 3. The first member 1 includes an approximately cylindrical portion 1a having a storage portion 1c, and a disk-shaped portion 1b that extends continuously from the approximately cylindrical portion 1a and has a larger diameter than the approximately cylindrical portion 1a. The second member 2 includes a hollow approximately cylindrical portion 2a, and a disk-shaped portion 2b that extends continuously from the approximately cylindrical portion 2a and has a larger diameter than the approximately cylindrical portion 2a, and the disk-shaped portion 2b is provided with a through hole 2c. The third member 3 includes a hollow approximately cylindrical portion 3a, and a hollow conical portion 3b with a bottom that is continuous with the approximately cylindrical portion 3a. As shown in Fig. 19(B), the second member 2 can be fitted into the first member 1 so that the approximately cylindrical portion 2a of the second member 2 fits into the approximately cylindrical portion 1a of the first member from the outside.

[0135] As shown in FIG. 19(B), 100 μm of 1 mM hydrogen peroxide solution was added to the storage section 1c of the first member 1. Next, a membrane 4 made of regenerated cellulose was provided so as to cover the cross section of the approximately cylindrical section 1a of the first member 1, and the membrane 4 was installed between the first member 1 and the second member 2 by fitting the second member 2 to the first member 1. The assembly of the first member 1 and the second member 2 in FIG. 19(B) was inverted, and the second member was inserted and arranged in the third member so that the disk-shaped portion 2b of the second member contacted the inside of the conical section 3b of the third member 3 and stopped, as shown in FIG. 19(C). The hydrogen peroxide solution in the storage section 1c of the approximately cylindrical section 1a of the first member 1 was passed through the membrane 4 in the direction of the arrow, and dialysis was performed for 50 minutes. 2.8 ml of distilled water was used for dialysis, and this was placed in the conical section 3b in advance.

[0136] The transmitted sample 5 accumulated inside the cone portion 3b was reacted with a fluorescent reagent (HYDROP-EX) for one hour, and the concentration of hydrogen peroxide was measured with a spectrofluorometer.

[0137] (result) Compared to the control membrane (regenerated cellulose membrane soaked in distilled water for 48 hours), the hydrogen peroxide concentration was reduced in dialysis using the PVIm-Me(25) / Mn-TCPP membrane prepared in Example 1 and the PVIm-Oc(23) / Mn-TCPP membrane prepared in Example 2 (Figure 20). This is consistent with the results of the oxygen production experiment, where the PVIm-Me(25) / Mn-TCPP membrane, which produced the highest amount of oxygen, also showed the greatest reduction in hydrogen peroxide concentration. This result of oxygen production and reduction in hydrogen peroxide suggests that disproportionation of hydrogen peroxide took place.

[0138] Example 6 Measurement of oxygen production in serum proteins The PVIm-Me(25) / Mn-TCPP membrane prepared in Example 1 was incubated in 10% fetal bovine serum (FBS) at 37°C for 1 hour. The dialysis membrane was directly placed in the oxygen electrode, and 900 μl of distilled water was added and the electrode was left to stand until the value stabilized. After the value stabilized, 100 μl of 10 mM hydrogen peroxide was added and the measurement was performed (final concentration 1 mM).

[0139] (result) Oxygen generation was also confirmed in the control membrane (regenerated cellulose membrane soaked in distilled water for 48 hours), but it is believed that the biological components in the FBS reacted and were detected as oxygen generation. Compared to the control membrane, a large amount of oxygen was generated in the membrane incubated in 10% FBS. In addition, the control membrane produced almost the same amount of net oxygen generation as the membrane in the absence of serum (Figure 21). Therefore, it is believed that catalytic activity was active even in serum proteins (FBS).

[0140] The composite material for the decomposition of hydrogen peroxide in this example, in which a PVIm derivative polymer and manganese or tetrakis(4-benzoic acid)porphyrin (Mn-TCPP) are non-covalently bonded to a dialysis membrane in a layer-by-layer manner, is a functional dialysis membrane that has on its surface a pseudo-active center that mimics catalase, an enzyme that disproportionates hydrogen peroxide, and is expected to lead to the development of a new device that can disproportionate hydrogen peroxide while performing the function of dialysis.

[0141] To summarize the results of the above examples, the generation of oxygen was confirmed in the dialysis membrane whose surface was modified with PVIm derivatives and Mn-TCPP, and the change in the amount of adsorption before and after the experiment was almost completely suppressed. In particular, the amount of adsorption did not change much before and after the experiment in the PVIm-Me(25) / Mn-TCPP membrane, and oxygen generation and decomposition of hydrogen peroxide were confirmed, suggesting that catalytic activity was observed on the dialysis membrane surface. In addition, the generation of oxygen due to catalytic activity was confirmed even in serum proteins, suggesting the possibility of blood compatibility. [Explanation of symbols]

[0142] 10...Composite material for decomposing hydrogen peroxide.

Claims

1. A solid support; a complex bound to a solid support, capable of catalyzing a reaction for decomposing hydrogen peroxide into oxygen and water, the complex comprising: a polyvinylimidazole in which the nitrogen at the 3-position of the imidazole ring is unsubstituted or in which an alkyl or alkenyl group is bound to the nitrogen at the 3-position of some of the imidazole rings; and a metalloporphyrin compound in which the central metal of the porphyrin skeleton is a manganese atom, an iron atom, a copper atom, or a selenium atom; A composite material for decomposing hydrogen peroxide comprising:

2. 2. The composite material for decomposing hydrogen peroxide according to claim 1, wherein the complex is bound to the solid support by a non-covalent bond, and the polyvinylimidazole and the metalloporphyrin compound are bound to each other by a non-covalent bond.

3. 3. The composite material for decomposing hydrogen peroxide according to claim 1, wherein the composite is represented by the following formula (4): 【Chemistry 1】 (In the formula, m is 0≦m<1, R is an optionally substituted alkyl group having 1 to 20 carbon atoms or an optionally substituted alkenyl group having 1 to 20 carbon atoms, and when the alkyl group having 1 to 20 carbon atoms or the alkenyl group having 1 to 20 carbon atoms is substituted, the substituent is at least one selected from the group consisting of a carboxy group, a hydroxy group, an amino group, and an amido group; Ar 1 , Ar 2 , Ar 3 , and Ar 4 each independently represents a substituted or unsubstituted arylene group or a substituted or unsubstituted heteroaromatic ring group, M is a manganese atom, an iron atom, a copper atom, or a selenium atom; X - is COO - Or S.O. 3 - It is.)

4. 2. The composite material for decomposing hydrogen peroxide according to claim 1, wherein the solid support is negatively charged and the polyvinylimidazole is non-covalently bound to the solid support.

5. The composite material for decomposing hydrogen peroxide according to claim 1 , wherein the solid support is a membrane that allows hydrogen peroxide to pass through.

6. 2. The composite material for decomposing hydrogen peroxide according to claim 1, wherein an introduction rate of the alkyl group in the polyvinylimidazole is 1 mol % to 99 mol %.

7. 2. The composite material for decomposing hydrogen peroxide according to claim 1, wherein the polyvinylimidazole has a number average molecular weight of 1,000 to 100,000.

8. The composite material for decomposing hydrogen peroxide according to claim 1, which is used for decomposing hydrogen peroxide in a biological sample.

9. A method for producing a composite material for decomposing hydrogen peroxide, comprising the steps of: Step (1): A step of binding one of the following (i) and (ii) to a solid support: (i) Polyvinylimidazole in which the nitrogen at the 3-position of the imidazole ring is unsubstituted or an alkyl or alkenyl group is bonded to the nitrogen at the 3-position of some of the imidazole rings. (ii) A metalloporphyrin compound in which the central metal of the porphyrin skeleton is a manganese atom, an iron atom, a copper atom, or a selenium atom. , and Step (2): binding one of (i) and (ii) to the other of (i) and (ii) bound to the solid support; The method, wherein the (i) polyvinylimidazole and the (ii) metalloporphyrin compound bonded to each other are capable of catalyzing the reaction of decomposing hydrogen peroxide into oxygen and water.

10. 9. The method of claim 8, wherein step (1) comprises contacting a negatively charged solid support with the polyvinylimidazole, and step (2) comprises contacting the solid support contacted with the polyvinylimidazole with a metalloporphyrin compound.

11. The method according to claim 8 , wherein the polyvinylimidazole is a compound represented by the following formula (1): 【Chemistry 2】 (In the formula, m is 0≦m<1, R is an optionally substituted alkyl group having 1 to 20 carbon atoms or an optionally substituted alkenyl group having 1 to 20 carbon atoms, and when the alkyl group having 1 to 20 carbon atoms or the alkenyl group having 1 to 20 carbon atoms is substituted, the substituent is at least one selected from the group consisting of a carboxy group, a hydroxy group, an amino group, and an amido group.

12. The method according to claim 8, wherein the metalloporphyrin compound is bound to the solid support in step (1) or bound to the polyvinylimidazole bound to a solid support in step (2), and the metalloporphyrin compound before binding in step (1) or step (2) is a compound represented by the following formula (3): 【Chemistry 3】 (In the formula, Ar 1 , Ar 2 , Ar 3 , and Ar 4 each independently represents a substituted or unsubstituted arylene group or a substituted or unsubstituted heteroaromatic ring group, M is a manganese atom, an iron atom, a copper atom, or a selenium atom; Y is COOH, SO 3 H, or a salt thereof.